Program Agenda | Webinar2025

PROGRAM AGENDA

Saturday, July 19, 2025

Time Zones

PST CST EST
A.M. A.M. A.M.

6:45 8:45 9:45 Please Login using the Zoom invite that is emailed to attendees a week before the Seminar

Legal Aspects of Cannabinoids, Terpenes and Flavonoids

7:00 9:00 10:00 Panel Moderator: The Honorable Noma Gurich, Justice, Oklahoma Supreme Court, Oklahoma City, OK

Panelists:

1. Adria Berry, JD, Executive Director, Oklahoma Medical Marijuana Authority, Oklahoma City, OK

2. Sandra Benischek Harrison, JD MPA, Executive Director, Oklahoma State Board of Medical Licensure & Supervision, Oklahoma City, OK

3. The Honorable Richard Wilbur, MD, JD, FCLM, DABLM, ACLM Alternate Delegate to the AMA,

4. Peter Rheinstein, M.D., J.D., MS, Physician; Attorney; President, Severn Health Solutions; Chair, USAN, Council; Chair, American Board of Legal Medicine. Since 2012, Peter has been Chairman of the United States Adopted Names (USAN) Council which assigns the generic names for all drugs marketed in the US. He represents the Maryland State Medical Society at the United States Pharmacopeia (USP) and the Academy of Physicians in Clinical Research (APCR) in the American Medical Association (AMA) House of Delegates. He is Treasurer and a Past President of APCR. Previously, over 25 years at the US Food and Drug Administration (FDA), Peter was responsible for implementing the generic drug law and for regulating prescription drug promotion. Peter is a consultant on medical law and regulation.

TOPICS:

(1) Cannabis Federal Law, Rules, Regulations, and AMA Guidelines - Rescheduling of THC to Schedule III

(2) State Rules, Regulations and Guidelines, & State Prescription Drug Monitoring Programs (PDMPs).

(3) Patients' Rights

(4) Physicians' duty and Responsibility

(5) Creation of the Physician-Patient Relationship

(6) Informed Consent

(7) Medical Marijuana Patient Contract

(8) Documentation - Accurate and Complete Medical Records

(9) Follow-up, Consultation

(10) Licensing of Providers, Liability Issues and Licensing Board Actions

Will Also Answer Questions from Attendees gathered on Chat.

Clinical Case Scenarios Involving Uses of Cannabis Products

Speakers:

S. Sandy Sanbar, MD, PHD, JD, FCLM, DABLM, Program Chair, Executive Director and Past Chairman, ABLM,

Past President, ACLM, Oklahoma City, Approved Instructor by the Medical Board of California.

Author: Human & Plant Cannabinoids, Terpenes & Flavonoids; Editor: Legal Medicine Health Care Law & Medical Ethics, 8th Ed., Elsevier 2024.

Richard J. Kelly, MD, JD, MPH, FASA, FCLM, DABLM, Clinical Professor, University of California, Irvine Trustee, American Board of Legal Medicine; Board Member and Lecturer, AELM, Approved instructor by the Medical Board of California
President-Elect, American Board of Legal Medicine

8:00 10:00 11:00 (1) Clinical Case Presentation: Cannabinoid Use Disorder (CUD) - Symptoms, Diagnostic Criteria and Treatment

(2) Clinical Case Presentation: Cannabinoid Hyperemesis Syndrome (CHS) - caused by excessive use of THC

(3) Endocannabinoid Deficiency Syndrome - caused by low 2-AG and Anandamide

8:30 10:30 11:30 Clinical Case Scenarios dealing with the following topics:

(1) The Human Endocannabinoid System

(2) Pharmacogenomics (Pharmaco-GX) of Cannabis Compounds

(3) Major and Minor Plant (Phyto-) Cannabinoids

(4) Pharmacokinetics and Pharmacodynamics of:

(a) Human Endocannabinoids.

(b) Plant (Phyto-) Cannabinoids

9:00 11:00 12:00 (1) Clinical Uses of Cannabinoids, terpenes and Flavonoids for Medical Conditions.

(2) Drug-Drug Interactions with Opioids, Benzodiazepines, Anti-depressant and Other Drugs

9:30 11:30 12:30 Risks and Adverse Events

Panel Questions and Answers: All Faculty
Will Also Answer Questions from Attendees gathered on Chat.

10:00 12:00 1:00 Adjourn